Fujirebio Diagnostics, Inc. is a premier diagnostics company and the industry leader in biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and commercialization of in-vitro diagnostic products for the management of human disease states, with an emphasis in oncology.
Given its size, Fujirebio Diagnostics was spending too much time spent on manually reviewing reports and the existing paper-based system was time-consuming and vulnerable to reporting errors.
Fujirebio Diagnostics implements an equipment monitoring system based on Wonderware System Platform and Wonderware Skelta BPM to ensure compliance for extensive reporting and documentation requirements from regulatory authorities.
The success story is also a classic illustration of the integration capabilities of Wonderware Skelta BPM with System Platform.